Isotope labelled Dasatinib (D193600), A new, oral, small-molecule Tyrosine Kinase Inhibitor (TKI) for the treatment of CML. Antineoplastic. It is a COVID19-related research product.
PROMPT×
PROMPT
The What'sApp is temporarily not supported in mainland China